Remove Communication Remove Definition Remove Documentation
article thumbnail

Pharmacist to Clinical Strategy Leader: Brendan Doran on Building a Career in Biotech

The Nontraditional Pharmacist

And then how do you develop documents to basically get approval from the FDA to study your drug in humans? So much smaller, much leaner and definitely more startup mentality. So there’s still definitely a lot of PharmD in there. So I definitely think looking for those types of roles with CROs.

FDA
article thumbnail

The GLP-1 Gold Rush: Why Compounded Alternatives Are a Risky Bet

Pharmaceutical Commerce

Compounding, by definition, involves customizing medications to meet individual patient needs, such as altering dosage forms or removing allergens. Maintain unwavering transparency with patients, unequivocally communicating the non-FDA approved status of compounded medications and all associated risks, securing explicit informed consent.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Research Suggests Vitamin D Deficiency Is a Risk Factor for Autism

Pharmacy Times

Autism Spectrum Disorder (ASD) impacts social communication, behavior, and daily functioning. As evidence evolves, pharmacists can lead in translating research into practice—implementing screening, personalized dosing, and interprofessional coordination while awaiting definitive trial results. 1-4 REFERENCES 1. 2024;16:59–91.

article thumbnail

Small Change: FDA’s Final Predetermined Change Control Plan (PCCP) Guidance Ditches ML and Adds Some Details, But Otherwise Sticks Closely to the Draft

The FDA Law Blog

FDA provides definitions for the three datasets. The update procedures should include how the AI-DSF modifications will be implemented and communicated to end users. Impact Assessment The Impact Assessment documents the benefits and risks of implementing the AI-DSF and the mitigations for the identified risks.

FDA
article thumbnail

It’s the Law Now –Cybersecurity Information in Premarket Submissions

The FDA Law Blog

The primary vehicle for FDA to request cybersecurity information in premarket submissions has been guidance documents. The technological characteristics in this context may cover a wide range of device functions, for instance, monitoring features, stimulation parameters, and communications with healthcare providers.

FDA
article thumbnail

Why We All Need Critical Thinking

ISPE

Originating outside our industry, and enthusiastically embraced by academic institutions and consultants globally, most of the definitions are somewhat unintelligible and hard to relate back to real life. offers no less than eleven different definitions and three sub-definitions. Critical thinking is one such buzz phrase.

article thumbnail

New regulatory relief to benefit Europe’s pharma SMEs

European Pharmaceutical Review

As small and medium-sized enterprises (SMEs) often face unfair competition when doing business in Europe, through the (SME) Relief Communication, the European Commission (EC) has proposed new measures to provide short-term relief, boost long-term competitiveness, and improve equality in the business environment across the Single Market in Europe.